XML 15 R4.htm IDEA: XBRL DOCUMENT v3.19.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Revenue:    
Product revenue $ 1,745,784 $ 1,933,944
Support and services revenue 2,747,194 3,060,005
Total revenue 4,492,978 4,993,949
Cost of revenue:    
Product 79,669 26,150
Support and service 563,745 728,888
Total cost of revenue 643,414 755,038
Gross profit 3,849,564 4,238,911
Operating expenses:    
Research and development costs 947,384 1,004,698
Selling and marketing 1,040,289 1,193,550
General and administrative 1,476,296 1,654,940
Restructuring costs (benefit) 157,693 (173,263)
Total operating expenses 3,621,662 3,679,925
Operating income 227,902 558,986
Interest and other income (loss), net (265,223) 10,330
Income (loss) before income taxes (37,321) 569,316
Income tax expense 87,586 62,439
Net income (loss) (124,907) 506,877
Less: Accrual of Series A redeemable convertible preferred stock dividends 247,027 243,167
Less: Deemed dividend on Series A redeemable convertible preferred stock 0 2,269,042
Less: Accretion to redemption value of Series A redeemable convertible preferred stock 129,239 38,105
Net loss attributable to common stockholders $ (501,173) $ (2,043,437)
Basic net loss per share attributable to common stockholders (in dollars per share) $ 0.00 $ (0.05)
Diluted net loss per share attributable to common stockholders (in dollars per share) $ 0.00 $ (0.05)
Weighted average basic shares outstanding (in shares) 588,798,795 44,564,094
Weighted average diluted shares outstanding (in shares) 588,798,795 44,564,094